The latest news from Van der Laan & Science.

We were awarded AtheroNETH: finding biomarkers and druggable targets for personalized primary prevention.
Unraveling the Heart of Type 1 Diabetes: on our U01 grant to study the immune-link between type 1 diabetes, type 2 diabetes and cardiovascular disease.
We were awarded this project which aims to develop a data-driven approach to AI-based phenotyping of atherosclerosis. We aim to deep-phenotype plaques and discover novel biomarkers for patient stratification.
Together with the Miller lab we will execute an integrative single-cell meta-analysis for atherosclerosis funded by the Chan Zuckerberg Initiative.
We collaborated with the Miller Lab to create PlaqView: a portal to plaque single-cell data.

Tim S. Peters 3/14/25 Tim S. Peters 3/14/25

PHENOMICL: detecting bleeding in atherosclerotic plaques

Together with collaborators from the University of Virginia , and Human Technopole we have developed an advanced AI system that can automatically detect and measure intraplaque haemorrhages.

Sander W. van der Laan 2/7/25 Sander W. van der Laan 2/7/25

dr. Joost Mekke

The ink is dry. Joost Mekke successfully presented and defended his thesis.

Sander W. van der Laan 12/5/24 Sander W. van der Laan 12/5/24

AtheroNETH

AtheroNETH: finding biomarkers and druggable targets for personalized primary prevention.

Sander W. van der Laan 10/11/24 Sander W. van der Laan 10/11/24

CaRe-T1D

Unraveling the Heart of Type 1 Diabetes: on our U01 grant to study the immune-link between type 1 diabetes, type 2 diabetes and cardiovascular disease.